[S-39] Symposium 39
The concept of MOG-IgG positive diseases

[S-39-3] Immunological features of MOG-IgG diseases

^○Kimihiko Kaneko^1,2 (1.Department of Neurology, NHO Miyagi National Hospital, Japan, 2.Department of Neurology, Tohoku University, Japan)

Auto-antibodies (IgG) against myelin oligodendrocyte glycoprotein (MOG) are detected in the serum of patients with various demyelinating diseases. These patients are known to show repeated clinical episodes of inflammatory demyelinating attacks in the central nervous system. Although the associated pathogenicity and mechanism of inflammatory demyelination remains inconclusive, it is known that patients with MOG-IgG have a different clinical spectrum from those with other demyelinating diseases, such as multiple sclerosis. We conducted this symposium to understand the clinical features and the spectrum of MOG-IgG related demyelinating diseases.

2009　　Graduated from Kitasato University
2009～　Tohoku University Hospital
2011～　Department of Neurology, Tohoku University Hospital
2012～　Department of Neurology, Tohoku Welfare Pension Hospital
2013～　Department of Neurology, Tohoku Pharmaceutical University Hospital
2014～　Department of Neurology, Tohoku University Graduate School of Medicine
2018～　Department of Neurology, National Hospital Organization Miyagi National Hospital